Our main focus: Common diseases such as asthma, allergies and chronic obstructive pulmonary disease (COPD), as well as infection-related inflammation of the lungs, in particular tuberculosis (TB).
02.02.2026
The FZB has received confirmation of its “audit berufundfamilie” certification from the board of trustees of berufundfamilie Service GmbH. This is the third time that the FZB has been awarded the certificate with distinction in special recognition of its long-standing, sustainable family- and life-phase-conscious personnel policy. The certificate is regarded as a seal of quality for a strategically designed work-life balance policy.
30.01.2026
A study by the Research Center Borstel, Leibniz Lung Center (FZB) on the role of interleukin (IL 6) in severe asthma exacerbations following viral infections has been selected as recommended reading by the editors of the journal Allergy. The publication is highlighted in the current January The publication is highlighted in the current January issue and is thus receiving special attention in the professional community.
27.01.2026
Last week, the course was set for an international exchange program in the field of tuberculosis research at the Borsteler Herrenhaus. At a joint meeting with Prof. Diganta Sarma and Dr. Kalyanjyoti Deori from the Department of Chemistry at Dibrugarh University (Assam, India), members of the Borsteler Executive Board signed a Memorandum of Understanding aimed at strengthening scientific cooperation between the two ins
10.02.2026
Borstel
02.-03.03.2026
Universitätsklinikum Würzburg
24.03.2026
Online